Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Apr 29, 2024 >>   ABB 6451.7 [ 0.67 ]ACC 2526.15 [ 0.07 ]AMBUJA CEM 629.8 [ -0.36 ]ASIAN PAINTS 2868.1 [ 0.83 ]AXIS BANK 1159.45 [ 2.60 ]BAJAJ AUTO 8759.8 [ -2.29 ]BANKOFBARODA 272.7 [ 1.70 ]BHARTI AIRTE 1333.25 [ 0.58 ]BHEL 276.8 [ -0.72 ]BPCL 618.7 [ 1.53 ]BRITANIAINDS 4800.95 [ 0.07 ]CIPLA 1407.55 [ -0.13 ]COAL INDIA 453.2 [ -0.52 ]COLGATEPALMO 2826.5 [ -1.01 ]DABUR INDIA 506.65 [ -0.46 ]DLF 886.25 [ -2.36 ]DRREDDYSLAB 6293.5 [ 0.64 ]GAIL 209.55 [ 0.72 ]GRASIM INDS 2388.05 [ 1.82 ]HCLTECHNOLOG 1387.1 [ -5.79 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1528.8 [ 1.26 ]HEROMOTOCORP 4458.4 [ -0.74 ]HIND.UNILEV 2226.95 [ 0.25 ]HINDALCO 650.2 [ 0.10 ]ICICI BANK 1158.8 [ 4.67 ]IDFC 121.65 [ -4.40 ]INDIANHOTELS 583.1 [ 2.60 ]INDUSINDBANK 1487.75 [ 2.90 ]INFOSYS 1435 [ 0.34 ]ITC LTD 438 [ -0.44 ]JINDALSTLPOW 941.9 [ 1.07 ]KOTAK BANK 1640.25 [ 1.98 ]L&T 3633.9 [ 0.88 ]LUPIN 1637.55 [ 1.34 ]MAH&MAH 2062.85 [ 0.91 ]MARUTI SUZUK 12695.75 [ 0.07 ]MTNL 37.61 [ 0.13 ]NESTLE 2510.6 [ 1.08 ]NIIT 107.8 [ -0.09 ]NMDC 254.9 [ -1.12 ]NTPC 363.1 [ 2.07 ]ONGC 283.3 [ 0.16 ]PNB 137.25 [ 0.59 ]POWER GRID 293.7 [ 0.55 ]RIL 2930.5 [ 0.95 ]SBI 826.15 [ 3.09 ]SESA GOA 406.3 [ 2.43 ]SHIPPINGCORP 232.45 [ 0.02 ]SUNPHRMINDS 1521.95 [ 1.18 ]TATA CHEM 1099 [ -2.09 ]TATA GLOBAL 1098.9 [ -0.36 ]TATA MOTORS 1000.45 [ 0.11 ]TATA STEEL 167.4 [ 0.93 ]TATAPOWERCOM 448.1 [ 2.60 ]TCS 3870.6 [ 1.51 ]TECH MAHINDR 1288.8 [ 0.89 ]ULTRATECHCEM 9962.25 [ 2.70 ]UNITED SPIRI 1180.6 [ -1.59 ]WIPRO 462.95 [ -0.37 ]ZEETELEFILMS 149.35 [ 2.33 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE   ` 169.10   Open: 175.40   Today's Range 168.65
175.40
-3.10 ( -1.83 %) Prev Close: 172.20 52 Week Range 70.20
185.40
Year End :2023-03 

Marksans Pharma Limited

Report on the Audit of the Standalone Financial StatementsOpinion

We have audited the accompanying standalone financial statements of Marksans Pharma Limited (“the Company”), which comprise the Balance Sheet as at March 31, 2023, and the Statement of Profit and Loss (Including Other Comprehensive Income), Statement of Changes in Equity and Statement of Cash Flows for the year then ended, and notes to the standalone financial statements, including a summary of significant accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 (“the Act’) in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards prescribed under section 133 of the Act read with Companies (Indian Accounting Standards) Rules, 2015, as amended (“Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2023, and profit, other comprehensive income, changes in equity and its cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor’s Responsibilities for the Audit of the Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (ICAI) together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the

standalone financial statements for the year ended March 31, 2023. We have determined that there are no key audit matters to communicate in our report.

Information Other than the Standalone Financial Statements and Auditor’s Report Thereon

The Company’s Board of Directors is responsible for the other information. The other information comprises the information included in the Management Discussion and Analysis, Board’s Report including Annexures to Board’s Report, Business

Responsibility and Sustainability Report, Corporate Governance and Shareholder’s Information, but does not include the standalone financial statements and our auditor’s report thereon. The Management Discussion and Analysis, Board’s Report including Annexures to Board’s Report, Business

Responsibility and Sustainability Report, Corporate Governance and Shareholder’s Information is expected to be made available to us after the date of this auditor’s report.

Our opinion on the standalone financial statements does not cover the other information and we will not express any form of assurance conclusion thereon.

In connection with our audit of the standalone financial statements, our responsibility is to read the other information identified above when it becomes available and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated.

When we read the Management Discussion and Analysis, Board’s Report including Annexures to Board’s Report, Business Responsibility and Sustainability Report, Corporate Governance and Shareholder’s Information, if we conclude that there is a material misstatement therein, we are required to communicate the matter to those charged with governance under SA 720 ‘The Auditor’s responsibilities Relating to Other Information’.

Responsibilities of Management and Those Charged with Governance for the Standalone Financial Statements

The Company’s Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor’s Report) Order,

2020 (“the Order”), issued by the Central Government of

India in terms of sub-section (11) of section 143 of the Act, we

give in “Annexure B” a statement on the matters specified

in paragraphs 3 and 4 of the Order, to the extent applicable.

2. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books.

(c) The Balance Sheet, the Statement of Profit and Loss (including other comprehensive income), the Statement of Changes in Equity and the Statement of Cash Flow dealt with by this Report are in agreement with the books of account.

(d) In our opinion, the aforesaid standalone financial statements comply with the Accounting Standards specified under Section 133 of the Act.

(e) On the basis of the written representations received from the directors as on March 31, 2023 taken on record by the Board of Directors, none of the directors are disqualified as on March 31, 2023 from being appointed as a director in terms of Section 164 (2) of the Act.

(f) With respect to the adequacy of the internal financial controls with reference to standalone financial statements of the Company and the operating effectiveness of such controls, refer to our separate Report in “Annexure C”.

(g) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed in Note 42 the impact of pending litigations on its financial position in its standalone financial statements.

ii. The Company has made provision, as required under the applicable law or accounting standards, for material foreseeable losses, if any, on long-term contracts including derivative contracts - Refer Note 24 to the standalone financial statements.

view of the financial position, financial performance, changes in equity and cash flows of the Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under section 133 of the Act. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial statement that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, the Board of Directors is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those Board of Directors are also responsible for overseeing the Company’s financial reporting process.

Auditor’s Responsibilities for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

We give in “Annexure A” a detailed description of Auditor’s responsibilities for Audit of the Standalone Financial Statements.

Other Matter

The standalone financial statements of the Company for the year ended March 31, 2022, were audited by another auditor whose report dated May 30, 2022 expressed an unmodified opinion on those standalone financial statements.

Our opinion is not modified in respect of the above matter.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

iv. (a) The Management has represented that, to

the best of its knowledge and belief, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other persons or entities, including foreign entities (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(b) The Management has represented, that, to the best of its knowledge and belief, no funds have been received by the Company from any persons or entities, including foreign entities (Funding Parties), with the understanding, whether recorded in writing or otherwise, as on the date of this audit report, that the Company shall, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(c) Based on the audit procedures performed that have been considered reasonable and appropriate in the circumstances, and according to the information and explanations provided to us by the Management in this regard nothing has come to our notice that has caused us to believe that the representations

under sub-clause (i) and (ii) of Rule 11(e) as provided under (a) and (b) above, contain any material mis-statement.

v. The final dividend paid by the Company during the year in respect of the same declared for the previous year is in accordance with Section 123 of the Act to the extent it applies to payment of dividend.

The Board of Directors of the Company have declared interim dividend for the year after the closure of financial year ended March 31, 2023. The dividend declared is in accordance with Section 123 of the Act to the extent it applies to declaration of dividend. (Refer Note 17 on Other Equity to the standalone financial statements).

vi. As proviso to rule 3(1) of the Companies (Accounts) Rules, 2014 is applicable for the company only w.e.f. April 1, 2023, reporting under this clause is not applicable.

3. In our opinion, according to information, explanations given to us, the remuneration paid by the Company to its directors is within the limits laid prescribed under Section 197 of the Act and the rules thereunder.

For M S K A & Associates

Chartered Accountants

ICAI Firm Registration No. 105047W

Bhavik L. Shah

Partner

Membership No. 122071

UDIN: 23122071BGXNRN4810

Place: Mumbai

Date: May 30, 2023